Familiar hypercholesterolemia knowledge by health personnel in Dominican Republic
DOI:
https://doi.org/10.53732/rccsalud/04.02.2022.38Keywords:
familiar hypercholesterolemia, knowledge, cholesterolAbstract
Introduction: Familial hypercholesterolemia (FH) is a disease caused by various mutations with a variable incidence depending on its heterozygous or homozygous form. However, few cases are diagnosed and not all health personnel know about the disease. Material and Methods: An online survey based on Google Forms was conducted to measure the level of knowledge of health personnel about FH in the Dominican Republic. A questionnaire prepared by the authors based on the DUCTH criteria for hypercholesterolemia was used. Results: The predominance of health personnel who filled out the questionnaire was nutritionists; knowledge about the appropriate cut-off values for the diagnosis of FH was reported in 30% of the sample. Conclusions: It is imperative to increase knowledge of the health personnel on FH to reduce premature cardiovascular death.
References
Alonso R, Perez de Isla L, Muñiz-Grijalvo O, Mata P. Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care. Vasc Health Risk Manag. 2020; 16:11-25. 10.2147/VHRM.S192401
Alefishat E, Jarab AS, Al-Qerem W, Abu-Zaytoun L. Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia. Healthcare (Basel). 2021;9(7):813. 10.3390/healthcare9070813
McGowan MP, Cuchel M, Ahmed CD, Khera A, Weintraub WS, Wilemon KA, Ahmad Z. A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model. Am J Prev Cardiol. 2021;6:100170. 10.1016/j.ajpc.2021.100170
Peterson AL, Bang M, Block RC, Wong ND, Karalis DG. Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia. J Clin Med. 2021;10(14):3090. 10.3390/jcm10143090
Pederiva C, Capra ME, Viggiano C, Rovelli V, Banderali G, Biasucci G. Early Prevention of Atherosclerosis: Detection and Management of Hypercholesterolaemia in Children and Adolescents. Life (Basel). 2021;11(4):345. 10.3390/life11040345
Kinnear FJ, Wainwright E, Perry R, Lithander FE, Bayly G, Huntley A, Cox J, Shield JP, Searle A. Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis. BMJ Open. 2019;9(7):e030290. 10.1136/bmjopen-2019-030290
Brett T, Qureshi N, Gidding S, Watts GF. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part. Atherosclerosis. 2018; 277:399-406. 10.1016/j.atherosclerosis.2018.08.019
Moderators, de Ferranti SD, Kazi DS; Experts:, Bibbins-Domingo K, Daniels S, Howaniec B, Khera AV, Newman TB, Vernacchio L. Perspectives on Identifying and Treating Familial Hypercholesterolemia in Childhood. Clin Chem. 2021;67(10):1312-1317. 10.1093/clinchem/hvab157
Silva PRS, Jannes CE, Oliveira TGM, Gómez LMG, Krieger JE, Santos RD, Pereira AC. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia. Arq Bras Cardiol. 2018;111(4):578-584. 10.5935/abc.20180156
.png)
All the contents of this journal are licensed under a 